REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,745.50
Bid: 1,745.00
Ask: 1,745.50
Change: 12.00 (0.69%)
Spread: 0.50 (0.029%)
Open: 1,736.00
High: 1,750.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-British blue-chips trail Europe as Brexit deal hopes lift pound

Wed, 09th Oct 2019 10:21

* FTSE 100 up 0.1%, FTSE 250 down 0.1%

* GVC gains after forecast upgrade

* Just Eat tops blue-chip risers

By Muvija M and Shashwat Awasthi

Oct 9 (Reuters) - London's exporter-laden FTSE 100 lagged
its European peers on Wednesday, as sterling gained on a report
that the EU was ready to make a "major concession" on the Brexit
divorce deal, while Just Eat helped the index hold on to slim
gains.

The blue-chip index, whose components make
two-thirds of their earnings abroad, was slightly off the day's
highs but was still up 0.1% by 0858 GMT, while the FTSE 250
was down 0.1%.

A report that the European bloc was ready to offer a
concession to the contested Irish backstop plan lifted the
pound, with exporter stocks clinging to gains made earlier in
the session when Brexit sentiment was unclear.

Shares in companies that earn a chunk of their earnings in
the U.S. dollar including GlaxoSmithKline and Reckitt
Benckiser were still offering the most support to the
main index.

Just Eat climbed 2% to top the FTSE 100 leader-board,
after its Dutch rival Takeaway.com reported a surge in
quarterly orders.

GVC outperformed the midcap index with a 3% rise as
the Ladbrokes owner boosted its annual core earnings target for
the second time in three months on robust demand in its betting
shops despite tighter regulation.

That news helped rival William Hill gain 1.5%.

Financials, which have been hammered this year
due to the Hong Kong protests and fears of a recession, rose
0.6%.

The sub-index has plunged 6% since the start of 2019,
severely lagging a near 7% rise in the FTSE 100 over the same
period and being the only major sector with year-to-date losses.

The recovery comes ahead of the release of minutes from the
U.S. Federal Reserve's last meeting scheduled later in the day,
which could provide further insight on the extent to which the
world's biggest central bank will venture out to support any
slowdown.

With Sino-U.S. talks set to resume tomorrow and as the
chaotic Brexit process drags on, investor sentiment has been on
the cautious side since the new quarter began.

Those concerns also kept a lid on Wednesday's rise.

"Though a trade war breakthrough seems a distant prospect,
there is always an element of unpredictably where Trump is
concerned," Spreadex analyst Connor Campbell said.

"The next few days, then, are going to be nothing if not
interesting."

(Reporting by Muvija M in Bengaluru; Editing by Bernard Orr)

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.